RARE ALERT: Evonik said to have rekindled EURO 25 billion merger with Royal DSM - part 5

As I suspected, Cash magazine has got the wrong end of the stick.

Today's weakness in Clariant's shares can largely be pinned to comments from Evonik's biggest shareholder, who appears to be playing down a deal to reporters at Bloomberg.